Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 367)
Posted On: 04/21/2021 1:49:58 PM
Post# of 72444
Avatar
Posted By: Drano
Many or most critically ill COVID patients do not get better.

As far as giving Brilacidin with Remdesivir -- in this country, if Remdesivir is a possible and approved treatment, it would be unethical to have a control group that did not get Remdesivir (which might be considered standard-of-care in some hospitals).

Therefore, if you are going to introduce an investigational drug which may work, you CANNOT withhold Remdesivir.

I also remind you that in some press releases, IPIX stated that it appeared that there was a synergistic effect for Brilacidin with Remdesivir.













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site